甲状腺乳头状癌淋巴结转移的危险因素研究 进展综述
Research Progress on Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma
摘要: 甲状腺乳头状癌是最常见的甲状腺恶性肿瘤，其淋巴结转移状况是决定患者预后和指导临床治疗策略的核心要素。目前，尽管诊疗技术不断进步，但准确预测淋巴结转移风险仍是临床面临的挑战。本文旨在系统综述该领域的研究进展，重点探讨与淋巴结转移相关的各类危险因素，包括患者的临床病理特征、新兴的分子生物学标志物以及影像学评估手段的最新发现。通过梳理和整合现有文献，本文深入分析了这些因素在转移过程中的潜在作用机制及其对风险分层的预测价值，以期为临床实践中实现更精准的个体化风险评估、优化手术方案制定以及改善术后随访管理提供坚实的理论参考。
Abstract: Papillary thyroid carcinoma is the most common malignant tumor of the thyroid, and its lymph node metastasis status is a core element in determining patient prognosis and guiding clinical treatment strategies. Currently, despite continuous advancements in diagnosis and treatment technologies, accurately predicting the risk of lymph node metastasis remains a challenge faced by clinicians. This article aims to systematically review the research progress in this field, focusing on various risk factors associated with lymph node metastasis, including patients’ clinical pathological characteristics, emerging molecular biological markers, and the latest findings in imaging assessment methods. By organizing and integrating existing literature, this article deeply analyzes the potential mechanisms of these factors in the metastatic process and their predictive value for risk stratification, with the aim of providing a solid theoretical reference for achieving more precise individualized risk assessment, optimizing surgical planning, and improving postoperative follow-up management in clinical practice.
文章引用：李达标. 甲状腺乳头状癌淋巴结转移的危险因素研究 进展综述[J]. 临床医学进展, 2026, 16(3): 3859-3867. https://doi.org/10.12677/acm.2026.1631195

参考文献

[1] Aydın, O.U. and Özbaş, S. (2025) Risk Factors for Central Lymph Metastasis in Node-Negative Papillary Thyroid Carcinoma. Nigerian Journal of Clinical Practice, 28, 1337-1341. [Google Scholar] [CrossRef] 
[2] Hou, J., Zhang, Y., Fan, Y. and Wu, B. (2020) Risk Factors of Skip Lateral Lymph Node Metastasis in Papillary Thyroid Carcinoma. European Archives of Oto-Rhino-Laryngology, 278, 493-498. [Google Scholar] [CrossRef] [PubMed]
[3] Zhang, Q., Li, J., Shen, H., Bai, X., Zhang, T. and Liu, P. (2022) Screening and Validation of Lymph Node Metastasis Risk-Factor Genes in Papillary Thyroid Carcinoma. Frontiers in Endocrinology, 13, Article ID: 991906. [Google Scholar] [CrossRef] [PubMed]
[4] Peng, Y., Zhang, Z., Wang, T., Wang, Y., Li, C., Zuo, M., et al. (2023) Prediction of Central Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma by CT Radiomics. Academic Radiology, 30, 1400-1407. [Google Scholar] [CrossRef] [PubMed]
[5] Gong, J., Zhu, B., Liu, W., Shi, C., Xia, C., Zeng, L., et al. (2023) Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Retrospective Study. Hormone and Metabolic Research, 55, 315-322. [Google Scholar] [CrossRef] [PubMed]
[6] Sun, H. and Liu, M. (2023) Risk Factors Associated with Lymph Node Metastasis in Patients with Small Papillary Thyroid Carcinomas. International Journal of Clinical and Experimental Pathology, 16, 86-93.
https://pubmed.ncbi.nlm.nih.gov/37293137/
[7] Ngo, D.Q., Le, D.T., Ngo, Q.X. and Van Le, Q. (2022) Risk Factors for Lateral Lymph Node Metastasis of Papillary Thyroid Carcinoma in Children. Journal of Pediatric Surgery, 57, 421-424. [Google Scholar] [CrossRef] [PubMed]
[8] Zhou, L., Gao, C., Li, H., Liang, W., Zeng, Q. and Chen, B. (2020) isthmic Papillary Thyroid Carcinoma Presents a Unique Pattern of Central Lymph Node Metastasis. Cancer Management and Research, 12, 3643-3650. [Google Scholar] [CrossRef] [PubMed]
[9] Shao, L., Wang, Z., Dong, W., Sun, W. and Zhang, H. (2023) Risk Factors Associated with Preferential Lateral Lymph Node Metastasis in Papillary Thyroid Carcinoma. Cancer Medicine, 12, 20670-20676. [Google Scholar] [CrossRef] [PubMed]
[10] Kwon, H., Cheon, Y., Shin, S., Sung, E., Lee, J., Kim, I.J., et al. (2021) Risk Factors of Suprasternal Lymph Node Metastasis in Papillary Thyroid Carcinoma with Clinical Lateral Cervical Lymph Node Metastasis. Gland Surgery, 10, 512-520. [Google Scholar] [CrossRef] [PubMed]
[11] Zhou, L., Chen, G., Sheng, L., Liu, N., Zhang, B., Zeng, Q., et al. (2021) Influence Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: Hashimoto’s Thyroiditis Has a Weak Effect on Central or Lateral Lymph Node Metastasis. Cancer Management and Research, 13, 3953-3961. [Google Scholar] [CrossRef] [PubMed]
[12] Lai, Y., Gu, Y., Yu, M. and Deng, J. (2023) Younger than 55 Years Old and BRAF V600E Mutation Are Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinomas ≤ 1.0 cm but Not in > 1.0 cm. International Journal of General Medicine, 16, 1403-1414. [Google Scholar] [CrossRef] [PubMed]
[13] Nguyen, V.P.T., Kurohama, H., Akazawa, Y., Nguyen, T.N.A., Matsuda, K., Matsuoka, Y., et al. (2025) Associations of Clinicopathologic Features and Mutation Status with Lateral Lymph Node Metastasis as a Predictor of Disease-Free Survival in Papillary Thyroid Carcinoma. Pathology—Research and Practice, 269, Article ID: 155951. [Google Scholar] [CrossRef] [PubMed]
[14] Jin, S., Xu, C., Wang, L., Wei, J. and Wang, S. (2020) Impact of Lin28 on Lymph Node Metastasis in Papillary Thyroid Carcinoma. Oncology Letters, 21, Article No. 97. [Google Scholar] [CrossRef] [PubMed]
[15] Zhang, H., Li, X., Li, Y., Li, S., Yan, G. and Chang, W. (2025) Expression and Clinical Significance of AUF1 and HIF-1α in Papillary Thyroid Carcinoma. World Journal of Surgical Oncology, 23, Article No. 252. [Google Scholar] [CrossRef] [PubMed]
[16] Yao, F., Yang, Z., Li, Y., Chen, W., Wu, T., Peng, J., et al. (2022) Real-World Evidence on the Sensitivity of Preoperative Ultrasound in Evaluating Central Lymph Node Metastasis of Papillary Thyroid Carcinoma. Frontiers in Endocrinology (Lausanne), 13, Article ID: 865911. [Google Scholar] [CrossRef] [PubMed]
[17] Lu, J., Liao, J., Chen, Y., Li, J., Huang, X., Zhang, H., et al. (2023) Risk Factor Analysis and Prediction Model for Papillary Thyroid Carcinoma with Lymph Node Metastasis. Frontiers in Endocrinology (Lausanne), 14, Article ID: 1287593. [Google Scholar] [CrossRef] [PubMed]
[18] Tian, D., Li, X. and Jia, Z. (2024) Analysis of Risk Factors and Risk Prediction for Cervical Lymph Node Metastasis in Thyroid Papillary Carcinoma. Cancer Management and Research, 16, 1571-1585. [Google Scholar] [CrossRef] [PubMed]
[19] Zhong, X., Lu, Y., Yin, X., Wang, Q., Wang, F. and He, Z. (2022) Prophylactic Central Lymph Node Dissection Performed Selectively with cN0 Papillary Thyroid Carcinoma According to a Risk-Scoring Model. Gland Surgery, 11, 378-388. [Google Scholar] [CrossRef] [PubMed]
[20] Luo, X., Wang, J., Xu, M., Zou, X., Lin, Q., Zheng, W., et al. (2020) Risk Model and Risk Stratification to Preoperatively Predict Central Lymph Node Metastasis in Papillary Thyroid Carcinoma. Gland Surgery, 9, 300-310. [Google Scholar] [CrossRef] [PubMed]
[21] Xiao, W., Zhou, W., Yuan, H., Liu, X., He, F., Hu, X., et al. (2025) A Radiopathomics Model for Predicting Large-Number Cervical Lymph Node Metastasis in Clinical N0 Papillary Thyroid Carcinoma. European Radiology, 35, 4587-4598. [Google Scholar] [CrossRef] [PubMed]
[22] Wang, J.H., Wang, Z.H., Chen, Y.B. and Sun, Y.X. (2025) Risk Factors for Contralateral Central Lymph Node Metastasis in Unilateral Papillary Thyroid Carcinoma. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 60, 505-510.
[23] Gao, J., Xin, Y., Yang, L., Liu, Y., Tian, Z. and Shang, X. (2022) Risk Factors of Skip Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma. Journal of Clinical Otorhinolaryngology, Head, and Neck Surgery, 36, 528-532, 539.
[24] Li, Y., Ma, Y., Zheng, L. and He, Q. (2024) A Lasso-Based Model to Predict Lateral Lymph Node Metastasis in Unifocal Papillary Thyroid Carcinoma with Central Lymph Node Metastasis. Endocrine, 88, 185-193. [Google Scholar] [CrossRef] [PubMed]
[25] Huang, C., Hu, D., Zhuang, Y. and Su, X. (2022) Risk Factors and Prediction Model of Level II Lymph Node Metastasis in Papillary Thyroid Carcinoma. Frontiers in Oncology, 12, Article ID: 984038. [Google Scholar] [CrossRef] [PubMed]
[26] Zhao, L., Wang, L., Jia, X., Hu, X., Pang, P., Zhao, S., et al. (2020) The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated with a Poor Prognosis: A Systematic Review and Network Meta-analysis. Frontiers in Oncology, 10, Article ID: 540238. [Google Scholar] [CrossRef] [PubMed]
[27] Chu, Y., Wirth, L.J., Farahani, A.A., Nosé, V., Faquin, W.C., Dias-Santagata, D., et al. (2020) Clinicopathologic Features of Kinase Fusion-Related Thyroid Carcinomas: An Integrative Analysis with Molecular Characterization. Modern Pathology, 33, 2458-2472. [Google Scholar] [CrossRef] [PubMed]
[28] Yoo, J., Kim, M., Kim, H.K., Shin, D.Y., Jeon, M.J., Kim, B.H., et al. (2025) Next-Generation Sequencing of Targetable Gene Fusions in Radioiodine-Refractory Thyroid Cancer: A Multicenter Study. Endocrine-Related Cancer, 32, e250089. [Google Scholar] [CrossRef] [PubMed]
[29] Zhao, F., Zhu, S., Fang, J., Dong, H. and Zhu, C. (2023) Correlation of DNA Methylation and Lymph Node Metastasis in Papillary Thyroid Carcinoma. Head & Neck, 45, 1654-1662. [Google Scholar] [CrossRef] [PubMed]
[30] He, S., Arikin, A., Chen, J., Huang, T., Wu, Z., Wang, L., et al. (2021) Transcriptome Analysis Identified 2 New lncRNAs Associated with the Metastasis of Papillary Thyroid Carcinoma. ORL, 84, 247-254. [Google Scholar] [CrossRef] [PubMed]
[31] Islam, F., Zhou, Y. and Lam, A.K. (2022) Long Non-Coding RNAs Profiling Using Microarray in Papillary Thyroid Carcinoma. In: Lam, A.K., Ed., Papillary Thyroid Carcinoma, Springer, 135-148. [Google Scholar] [CrossRef] [PubMed]
[32] Xu, S., Jin, B., Zhao, W., Chen, X., Tong, Y., Ding, X., et al. (2022) The Specifically Androgen-Regulated Gene (SARG) Promotes Papillary Thyroid Carcinoma (PTC) Lymphatic Metastasis through Vascular Endothelial Growth Factor C (VEGF-C) and VEGF Receptor 3 (VEGFR-3) Axis. Frontiers in Oncology, 12, Article ID: 817660. [Google Scholar] [CrossRef] [PubMed]
[33] Hao, Z., Wang, Y., Li, J., Liu, W., Zhao, W. and Wang, J. (2023) Expression of HIF-1α/PKM2 Axis Correlates to Biological and Clinical Significance in Papillary Thyroid Carcinoma. Medicine (Baltimore), 102, e33232. [Google Scholar] [CrossRef] [PubMed]
[34] Tekin, E., Oflas, D., Badak, B., Kebapçi, N., Akalin, A. and Dündar, E. (2025) Prognostic Significance of Lin28A Protein Expression in Papillary Thyroid Carcinoma. Indian Journal of Pathology and Microbiology, 68, 486-491. [Google Scholar] [CrossRef] [PubMed]
[35] Guang, Y., He, W., Zhang, W., Zhang, H., Zhang, Y. and Wan, F. (2021) Clinical Study of Ultrasonographic Risk Factors for Central Lymph Node Metastasis of Papillary Thyroid Carcinoma. Frontiers in Endocrinology (Lausanne), 12, Article ID: 791970. [Google Scholar] [CrossRef] [PubMed]
[36] Zhao, J., Zheng, W., Zhong, M., Daming, L. and Guo, L. (2024) Risk Factors and Prognosis of Retropharyngeal Lymph Node Metastasis from Papillary Thyroid Carcinoma. Alternative Therapies in Health and Medicine, 30, 474-479.
https://pubmed.ncbi.nlm.nih.gov/39110049/
[37] Guo, J., Song, L., Yu, P., Yu, S., Deng, S., Mao, X., et al. (2020) Ultrasound Elastic Parameters Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma. Journal of Surgical Research, 253, 69-78. [Google Scholar] [CrossRef] [PubMed]
[38] Lo, C.Y. (2022) Lymph Node Dissection for Papillary Thyroid Carcinoma. In: Lam, A.K., Ed., Papillary Thyroid Carcinoma, Springer US, 57-78. [Google Scholar] [CrossRef] [PubMed]
[39] Hu, Q., Zhang, W., Liang, L., Li, L., Yin, W., Su, Q., et al. (2022) Establishing a Predictive Nomogram for Cervical Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma. Frontiers in Oncology, 11, Article ID: 766650. [Google Scholar] [CrossRef] [PubMed]
[40] Mirshahidi, S., Yuan, I.J., Simental, A., Lee, S.C., Peterson, N.R., Andrade Filho, P.A., et al. (2023) Targeting Tumor Microenvironment Akt Signaling Represents a Potential Therapeutic Strategy for Aggressive Thyroid Cancer. International Journal of Molecular Sciences, 24, Article No. 5471. [Google Scholar] [CrossRef] [PubMed]
[41] Luo, S., Lai, F., Liang, R., Li, B., He, Y., Chen, W., et al. (2024) Clinical Prediction Models for Cervical Lymph Node Metastasis of Papillary Thyroid Carcinoma. Endocrine, 84, 646-655. [Google Scholar] [CrossRef] [PubMed]
[42] Su, Y.J. and Cheng, R.C. (2025) Current Status and Controversies Surrounding Prophylactic Central Neck Lymph Node Dissection in Clinically Lymph Node-Negative Papillary Thyroid Carcinoma. Chinese Journal of Medical History, 105, 4338-4344.
[43] Pavlidis, E.T. and Pavlidis, T.E. (2023) Role of Prophylactic Central Neck Lymph Node Dissection for Papillary Thyroid Carcinoma in the Era of De-escalation. World Journal of Clinical Oncology, 14, 247-258. [Google Scholar] [CrossRef] [PubMed]
[44] Harries, V., McGill, M., Wang, L.Y., Tuttle, R.M., Wong, R.J., Shaha, A.R., et al. (2020) Is a Prophylactic Central Compartment Neck Dissection Required in Papillary Thyroid Carcinoma Patients with Clinically Involved Lateral Compartment Lymph Nodes? Annals of Surgical Oncology, 28, 512-518. [Google Scholar] [CrossRef] [PubMed]
[45] Canu, G.L., Medas, F., Conzo, G., et al. (2020) Is Prophylactic Central Neck Dissection Justified in Patients with cN0 Differentiated Thyroid Carcinoma? An Overview of the Most Recent Literature and Latest Guidelines. Annali Italiani di Chirurgia, 91, 451-457.
https://pubmed.ncbi.nlm.nih.gov/33295306/
[46] Raffaelli, M., Sessa, L., De Crea, C., Fadda, G., Princi, P., Rossi, E.D., et al. (2021) Is It Possible to Intraoperatively Modulate the Extent of Thyroidectomy in Small Papillary Thyroid Carcinoma? Surgery, 169, 77-81. [Google Scholar] [CrossRef] [PubMed]
[47] Ahn, J., Kwak, J.H., Yoon, S.G., Yi, J.W., Yu, H.W., Kwon, H., et al. (2022) A Prospective Randomized Controlled Trial to Assess the Efficacy and Safety of Prophylactic Central Compartment Lymph Node Dissection in Papillary Thyroid Carcinoma. Surgery, 171, 182-189. [Google Scholar] [CrossRef] [PubMed]

为你推荐